Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05451550
Other study ID # Gang202207
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 17, 2022
Est. completion date November 29, 2025

Study information

Verified date June 2022
Source General Hospital of Ningxia Medical University
Contact Gang Ma, doctor
Phone 13709519220
Email magang2671@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Controlled hypotension is one of the important techniques used for facilitates the clarity of the surgical field during arthroscopic shoulder surgery. Brachial plexus or its branches block provides excellent analgesia during arthroscopic shoulder surgery. To test the hypothesis that, during arthroscopic shoulder surgery, general anesthesia combined with nerve block could provide more stable hemodynamic index than general anesthesia. Patients undergoing arthroscopic shoulder surgery were enrolled and divided into 3 groups: general anesthesia group, general anesthesia combined with brachial plexus block, and general anesthesia combined with suprascapular nerve block group. The dosage of vasoactive drugs and anesthetics, parameters of perioperative bleeding, hemodynamic parameters, systemic oxygen metabolism, kidney functions, as well as procedure process and postoperative adverse reactions were recorded and compared between the groups.


Description:

Controlled hypotension is one of the important techniques used for minimizing bleeding and facilitates the clarity of the surgical field during arthroscopic shoulder surgery. Although surgical field visualization is important in arthroscopic shoulder surgery, the complications associated with controlled hypotension for surgery should be considered. The implementation of controlled hypotension requires a large amount of antihypertensive agents or anesthetics, it may cause instability of the circulatory system, organ hypoperfusion, or subsequent ischemic injury. Brachial plexus or its branches block provides excellent analgesia during arthroscopic shoulder surgery. However, few data are currently available in the literature evaluating brachial plexus or its branches block and controlled hypotension during arthroscopic shoulder surgery. To obtain more information on this topic, the investigators conducted this prospective randomized study to test the hypothesis that, during arthroscopic shoulder surgery, general anesthesia combined with nerve block could provide more stable hemodynamic index than general anesthesia. Methods: The inclusion criteria are (1) planned elective arthroscopic shoulder surgery, need controlled hypotension under general anesthesia; (2) aged 60-75 years; (3) ASA grade II or III; and (4) estimated operative time < 120 min. The exclusion criteria were (1) preoperative blood pressure systolic ≥ 160 mmHg or diastolic ≥ 100 mmHg or pulse pressure ≥ 60 mmHg; (2) comorbidities of severe cardiovascular disease, including cardiac function grade III or IV, severe aortic stenosis, aortic valve insufficiency, severe coronary heart disease, bradycardia, and atrioventricular block above degree I; (3) history of cerebral infarction, Alzheimer's disease, or cerebrovascular incident; (4) liver and/or kidney dysfunction; (5) severe anemia, shock, hypovolemia, or respiratory dysfunction; (6) previous history of phlebitis or thrombosis, closed-angle glaucoma; and (7) BMI > 25 or < 18. Patients with intraoperative blood loss > 1500 mL or operation time > 4 h would be further excluded from the analysis. The included patients were divided into 3 groups: general anesthesia group, general anesthesia combined with brachial plexus block, and general anesthesia combined with suprascapular nerve block group. For controlled hypotension during surgery, all patients were maintained with propofol/remifentanil in general anesthesia. An additional ultrasound-guided brachial plexus block or suprascapular nerve block were performed in general anesthesia combined with brachial plexus block or general anesthesia combined with suprascapular nerve block group. The dose of each agent was adjusted to maintain the mean arterial blood pressure (MAP) at 60 to 70 mm Hg and the BIS at 40 to 60. nicardipine and phenylephrine served mainly to control the target MAP, Norepinephrine and esmolol were also used as needed. The dosage of vasoactive drugs (vasopressor-inotrope dose was calculated by adding norepinephrine equivalents of total norepinephrine, epinephrine, phenylephrine, and vasopressin dose used during surgery, using the following formula: total vasopressor-inotrope dose = [norepinephrine (µg/min) × min] + [epinephrine (µg/min) × min] + [(phenylephrine (µg/min) ×min) ÷ 10] + [vasopressin (U/h) × 8.33 × min]) and anesthetics, parameters of perioperative bleeding, hemodynamic parameters(blood pressure, heart rate, pulse oximetry), systemic oxygen metabolism, kidney functions, as well as procedure process and postoperative adverse reactions were recorded and compared between the groups. The incidence of postoperative complications (within 7 days, such as Organ dysfunction) were also recorded. Statistical analysis and get conclusions.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date November 29, 2025
Est. primary completion date September 29, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - (1) planned elective arthroscopic shoulder surgery, need controlled hypotension under general anesthesia; (2) aged 60-75 years; (3) ASA grade II or III; and (4) estimated operative time < 120 min. Exclusion Criteria: - (1) preoperative blood pressure systolic = 160 mmHg or diastolic = 100 mmHg or pulse pressure = 60 mmHg; (2) comorbidities of severe cardiovascular disease, including cardiac function grade III or IV, severe aortic stenosis, aortic valve insufficiency, severe coronary heart disease, bradycardia, and atrioventricular block above degree I; (3) history of cerebral infarction, Alzheimer's disease, or cerebrovascular incident; (4) liver and/or kidney dysfunction; (5) severe anemia, shock, hypovolemia, or respiratory dysfunction; (6) previous history of phlebitis or thrombosis, closed-angle glaucoma; and (7) BMI > 25 or < 18. Patients with intraoperative blood loss > 1500 mL or operation time > 4 h would be further excluded from the analysis.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Brachial plexus block
An additional ultrasound-guided suprascapular nerve block(0.375% ropivacaine) were performed before general anesthesia induction in general anesthesia combined with brachial plexus block group
General anesthesia
General anesthesia were performed according to clinical routine: induction drugs: propofol, sufentanil, rocuronium, maintenance drugs: propofol, sevoflurane and remifentanil, Laryngeal mask ventilation.
Suprascapular nerve block
An additional ultrasound-guided suprascapular nerve block(0.375% ropivacaine) were performed before general anesthesia induction in general anesthesia combined with brachial plexus block group

Locations

Country Name City State
China Department of Anesthesiology, General Hospital of Ningxia Medical University Yinchuan Ningxia

Sponsors (1)

Lead Sponsor Collaborator
General Hospital of Ningxia Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The dosage of total vasopressor-inotrope dose between groups The dosage of total vasopressor-inotrope dose (Calculate by formula) between the groups 1 day
Secondary The dosage of anesthetics between groups The dosage of propofol(milligram) and sevoflurane(milliliter) between groups 1 day
Secondary Blood pressure between the groups Blood pressure(millimeter of mercury) between the groups 1 day
Secondary The incidence of postoperative complications The incidence of postoperative complications (within 7 days, such as Organ dysfunction) between groups 3 day
See also
  Status Clinical Trial Phase
Completed NCT06274827 - Electromyographic Analysis of Scapular Muscles During Closed Kinetic Chain Exercises N/A
Completed NCT04094246 - Battlefield Acupuncture Following Shoulder Surgery N/A
Active, not recruiting NCT05909592 - Shoulder Injury Rate and Risk Among CrossFit Participants in Greece. Εfficacy of an Innovative Prevention Program.
Not yet recruiting NCT04418063 - Glenohumeral Internal Rotation Deficit in Non-pitcher Overhead Athletic Athletes: Case Series Analysis of Athletes
Recruiting NCT05725603 - Clinical and Anatomical Evaluation of Healing of Lesions of the Subscapular Tendon N/A
Recruiting NCT05391516 - Developing a New Scale for Evaluating Shoulder Problems
Completed NCT04852640 - Mitigating the Impact of Shoulder Movement Dysfunction; a Randomized Controlled Trial N/A
Completed NCT04185064 - Cryopneumatic Device After Shoulder Surgeries N/A
Completed NCT04078945 - Risk Factors of Shoulder Injuries in Youth Volleyball Players
Completed NCT04641520 - Shoulder Profile Among Swimmers and Badminton Players
Enrolling by invitation NCT04003272 - MDR - Comprehensive Reverse/Versa Dial Ti Glenosphere
Completed NCT00631826 - Shoulder Rotational Flexibility and Throwing Arm Injuries of Baseball Pitchers N/A
Completed NCT00664794 - Rotator Cuff Repair With Arthroscopic Acromioplasty (Shaving the Acromion Bone) Versus Repair Without Acromioplasty N/A
Recruiting NCT04209504 - Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block
Terminated NCT04093700 - MDR SureLock All-Suture Anchor
Completed NCT04625816 - Comparison of Core Muscle Asymmetry Using Spine Balance 3D in Patients With Arthroscopic Shoulder Surgery N/A
Recruiting NCT05344898 - Subscap Reverse Shoulder Arthroplasty N/A
Recruiting NCT05064033 - Pragmatic Posterior Capsular Stretch Versus Sleeper Stretch in Subject With Shoulder Pathologies N/A
Completed NCT05397652 - The Aim of This Study is to Examine the Effect of Intravenously Administered Tranexamic Acid (TXA) on the Visual Clarity, Perioperative Hemorrhage, Duration and Early Postoperative Course of Shoulder Arthroscopy in Beach Chair Position. Phase 4
Not yet recruiting NCT05762588 - JuggerKnot With Broadband PMCF Study